Congress will return to session on Monday, April 17. The House of Representatives is in a District Work Period through Sunday, April 16, 2023, but will convene for a pro forma session on Monday, April 3. During the recess, the Senate will convene on Mondays and Thursdays for pro forma sessions only, with no business being conducted.
President to Sign Legislation Ending COVID-19 National Emergency
President Joe Biden plans to sign into law legislation passed by the Senate last week (H.J.Res. 7) that would terminate the COVID-19 national emergency early, despite White House opposition to the measure. The bill – which passed the House of Representatives on February 1 and cleared the Senate in a 68-23 vote on Wednesday – would immediately end the national emergency upon being signed by the President. Both the COVID-19 public health emergency (PHE) declared in January 2020, and the national emergency declared in March 2020 are set to expire on May 11 under the wind-down plan announced by the administration in January. While May 11 remains the expiration date of the COVID-19 PHE, the resolution will impact federal healthcare programs. Blanket waivers issued by the U.S. Department of Health and Human Services – including certain requirements for Medicare provider enrollment, requirements for in-person meetings between providers and patients, and requirements for out-of-state Medicare and Medicaid providers to be licensed in the state where they are providing services – were issued under the national emergency declaration. Some additional flexibilities issued to states and territories for the administration of their Medicaid and CHIP programs, like those permitting the provision of services in alternative settings and those to ease provider enrollment in the programs, are also tied to the national emergency declaration. Although the administration “strongly opposes” H.J.Res. 7, it “will continue working with agencies to wind down the national emergency with as much notice as possible to Americans who could potentially be impacted,” a White House official stated to The Hill. More information on the emergency declarations can be found in Hart Health Strategies Inc.’s primer on Public Health Emergencies and Major Disaster Declarations.
Judge Strikes ACA’s Preventive Services, HIV Treatment Coverage Mandates
U.S. District Court Judge Reed O’Connor has struck down the Affordable Care Act’s (ACA) preventive services coverage requirement. The requirement mandates that insurers and employers cover more than 100 preventive health services, e.g., mammograms and colonoscopies, recommended by the U.S. Preventive Services Task Force (USPSTF) for free. The judge for the Northern District of Texas ruled that the USPSTF is unconstitutional because its members wield power that resembles legislative authority without being appointed by the President and confirmed by the Senate. He also invalidated the law’s coverage mandate for HIV pre-exposure prophylactic (PrEP) drugs on the grounds that it violates the religious freedom of a Christian-owned company. The Biden administration is expected to appeal the decision.
Medicare Trustees Recommend Congress Address Projected Shortfalls
On Friday, the Medicare Boards of Trustees released their annual report on the Federal Hospital Insurance (Medicare Part A) and Federal Supplementary Medical Insurance (Medicare Part B) Trust Funds. The Trustees have again determined that the Part A trust fund “is not adequately financed over the next 10 years.” The depletion date is now 2031, 3 years later than last year’s projection. Expenditures exceeded income in 2022 and deficits are projected beginning in 2025. The Part A trust fund has failed to meet the Trustees’ formal short-range financial adequacy test since 2003. The Part B trust fund draws from general revenue and therefore is expected to be adequately financed through beneficiary premiums and federal funds. Upon the release of the report, CMS Administrator Chiquita Brooks-LaSure stated that “Everyone in the Biden-Harris Administration is committed to protecting Medicare, and we look forward to working with Congress to strengthen this vital program serving over 65 million Americans.”
E&C GOP Leaders Contact FDA on Drug Shortages, Gain-of-Function Research
House Energy and Commerce Committee Republican leadership have sent a letter to the Biden administration requesting information related to drug shortages. The lawmakers assert that the Food and Drug Administration (FDA) may not effectively be using its existing authorities to prevent or reduce ongoing drug shortages and request details about the scarcity of drugs to treat asthma, cancer, tuberculosis, bacterial infection, and headaches, pain, and fever – specifically seeking information on shortages of albuterol, Pluvicto, cisplatin, fluorouracil, methotrexate, Bacillus Calmette- Guerin (BCG), amoxicillin, acetaminophen, and ibuprofen. They point out that the agency has not yet released any information on the reports required by the Coronavirus Aid, Relief, and Economic Security Act from industry on listed drugs manufactured, prepared, or processed for commercial distribution and where active pharmaceutical ingredients and finished dosage forms were made. The letter to FDA Commissioner Robert Califf was signed by Chair Cathy McMorris Rodgers (R-Wash.), Health Subcommittee Chair Brett Guthrie (R-Ky.), and Oversight and Investigations Subcommittee Chair Morgan Griffith (R-Va.). The lawmakers request a response by April 13.
Rodgers, Guthrie, and Griffith also sent a separate letter to Commissioner Califf following up on prior questions posed to the agency about the FDA’s funding of gain-of-function research last week. While FDA staff have acknowledged that some agency research studies “involve virus manipulation, passaging of a virus, genetically modified animals, or making any mutations to a virus,” the latest letter requests additional details to put these studies in context and enable an assessment of the adequacy of FDA’s oversight of potential risks in such experiments. The lawmakers request a response to this letter by April 10.
Eshoo, Guthrie Call on FDA to Address Backlog of Cell and Gene Therapy Applications
House Energy and Commerce Health Subcommittee leadership Chairman Brett Guthrie (R-Ky.) and Ranking Member Anna Eshoo (D-Calif.) have sent a letter to the Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research Director Peter Marks expressing concerns about the increasing number of clinical holds on biologics license applications which delay a proposed clinical investigation or suspend an ongoing investigation for such products. They request details about the agency’s process for addressing these holds and “encourage the FDA to use its regulatory discretion where necessary to make these innovative products available to patients in need, particularly those with ultra-rare or fatal diseases or for whom there are limited or no treatment options. The full letter can be found here and requests a response no later than April 14.
Comer Requests Briefing on Regulation of Tobacco, Nicotine
House Oversight and Accountability Chairman James Comer (R-Ky.) has sent a letter to the Food and Drug Administration requesting information and a staff briefing on the Center for Tobacco Product’s (CTP) tobacco and nicotine regulatory programs. Comer references a recent evaluation by the Reagan-Udall Foundation, which found that CTP has not clearly detailed “the most basic elements” of such programs, resulting in “confusion, inefficiency, litigation, and suspicions of political interference.” The letter expresses concerns that the Center has allowed unsafe and unregulated products to proliferate on the market and requests a response from the agency no later than April 11.
Duckworth Urges FTC Intervention on Mifepristone Distribution
Sen. Tammy Duckworth (D-Ill.) is urging the Federal Trade Commission (FTC) to investigate AmerisourceBergen following reports that the company plans to limit the sale of mifepristone. AmerisourceBergen is the sole wholesale distributor of the brand-name version of the abortion medication. “The bottom line is that based on existing information, data and evidence, one cannot dismiss the possibility that AmerisourceBergen may be using broader political disagreements and active legal debates as pretextual cover and justification for engaging in anticompetitive, unfair, and deceptive practices that are primarily concerned with maximizing profit margins by reducing consumer choice and restricting trade with an entire industry of retail pharmacies,” Duckworth argues.
POLICY BRIEFINGS
Fetterman, Feinstein Expected to Return Following April Recess
Sen. John Fetterman (D-Pa.) plans to return to the Senate the week of April 17, according to sources close to the lawmaker. Fetterman announced in mid-February that he had checked himself into inpatient treatment at Walter Reed Medical Center and was seeking treatment for clinical depression on the recommendation of Congress’ attending physician. According to the American Stroke Association, depression is common among stroke survivors. Fetterman suffered a stroke on the campaign trail last year. Sen. Dianne Feinstein (D-Calif.) has also been absent from the chamber since being hospitalized following a shingles diagnosis over the February recess. Sen. Tim Kaine (D-Va.) stated that he expects her to return to the Senate in the days following the upcoming two-week congressional recess as well.
WHO Revises COVID Vaccine Recommendations
The World Health Organization (WHO) has revised its COVID-19 vaccine recommendations in response to the current phase of the disease and global immunity levels. WHO suggests that high-risk populations – older adults and people with significant risk factors – receive an additional dose of the vaccine either six or 12 months after their latest dose, based on factors like age and any immunocompromising conditions. The global health agency advises that countries consider factors like disease burden before recommending the vaccination of healthy children and adolescents.
Recently Introduced Health Legislation
H.R.1800 – To prohibit Federal spending on funding research in China, and for other purposes. Sponsor: Williams, Brandon [Rep.-R-NY-22]; Committees: House – Science, Space, and Technology
H.R.1795 – To amend the Internal Revenue Code of 1986 to allow qualified distributions from health savings accounts for certain home care expenses; Sponsor: Smith, Adrian [Rep.-R-NE-3]; Committee: House – Ways and Means
H.R.1790 – To direct the Secretary of Health and Human Services to evaluate the extent to which the substitution of interchangeable biological products is impacted by differences between the system for determining a biological product to be interchangeable and the system for assigning therapeutic equivalence ratings to drugs, and for other purposes; Sponsor: Miller-Meeks, Mariannette [Rep.-R-IA-1]; Committee: House – Energy and Commerce
H.R.1781 – To amend the Public Health Service Act with respect to the designation of general surgery shortage areas, and for other purposes; Sponsor: Bucshon, Larry [Rep.-R-IN-8]; Committee: House – Energy and Commerce
H.R.1780 – To facilitate the development of treatments for cancer, and for other purposes; Sponsor: Bilirakis, Gus M. [Rep.-R-FL-12]; Committees: House – Energy and Commerce; Ways and Means
H.R.1776 -End Tuberculosis Now Act of 2023- To prevent, treat, and cure tuberculosis globally; Sponsor: Bera, Ami [Rep.-D-CA-6]; Committee: House – Foreign Affairs
H.R.1774 – To amend title 38, United States Code, to reimburse veterans for the cost of emergency medical transportation to a Federal facility, and for other purposes; Sponsor: Alford, Mark [Rep.-R-MO-4]; Committees: House – Veterans’ Affairs
S.983 – A bill to permit the Attorney General to award grants for accurate date on opioid-related overdoses, and for other purposes; Sponsor: Scott, Rick [Sen.-R-FL]; Committees: Senate – Judiciary
S.986 – A bill to increase the criminal penalty for mail fraud involving misrepresentation of the country of origin, to terminate the authority to exclude countries from the requirement to transmit advance electronic information for 100 percent of mail shipments under the STOP Act of 2018, and for other purposes; Sponsor: Klobuchar, Amy [Sen.-D-MN]; Committees: Senate – Finance
H.Res.259 – Promoting youth mental health and well-being in a changing climate; Sponsor: Thompson, Mike [Rep.-D- CA-4]; Committees: House – Energy and Commerce
H.R.1805 – To mitigate the effects of the COVID-19 pandemic on incentives under the Federal Food, Drug, and Cosmetic for the development of orphan drugs, and for other purposes; Sponsor: Gottheimer, Josh [Rep.-D-NJ-5]; Committees: House – Energy and Commerce
S.993 – A bill to prohibit certain uses of xylazine, and for other purposes; Sponsor: Cortez Masto, Catherine [Sen.-D-NV]; Committees: Senate – Judiciary
S.996 – A bill to amend title XIX of the Social Security Act to establish a demonstration project to improve outpatient clinical care for individuals with sickle cell disease; Sponsor: Booker, Cory A. [Sen.-D-NJ]; Committees: Senate – Finance
S.1000 – A bill to amend title XVIII of the Social Security Act to improve the accuracy of market-based Medicare payment for clinical diagnostic laboratory services, to reduce administrative burdens in the collection of data, and for other purposes; Sponsor: Brown, Sherrod [Sen.-D-OH]; Committees: Senate – Finance
S.1001 – A bill to amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules; Sponsor: Daines, Steve [Sen.-R-MT]; Committees: Senate – Finance
S.1002 – A bill to amend title XVIII of the Social Security Act to improve risk adjustment under Medicare Advantage; Sponsor: Cassidy, Bill [Sen.-R-LA]; Committees: Senate – Finance
H.R.1825 – To clarify that the Federal Right to Try law applies to schedule I substances for which a phase I clinical trial has been completed and to provide access for eligible patients to such substances pursuant to the Federal Right to Try law; Sponsor: Blumenauer, Earl [Rep.-D-OR-3]; Committees: House – Energy and Commerce; Judiciary
H.R.1826 – To amend title XXVII of the Public Health Service Act to require group health plans and health insurance issuers offering group or individual health insurance coverage to provide coverage for prostate cancer screenings without the imposition of cost-sharing requirements, and for other purposes; Sponsor: Bucshon, Larry [Rep.-R-IN-8]; Committees: House – Energy and Commerce
H.R.1827 – To prohibit the National Institutes of Health from conducting or supporting certain gain-of-function research, and for other purposes; Sponsor: Carter, Earl L. “Buddy” [Rep.-R-GA-1]; Committees: House – Energy and Commerce
H.R.1835 – To amend title XVIII of the Social Security Act to improve the accuracy of market-based Medicare payment for clinical diagnostic laboratory services, to reduce administrative burdens in the collection of data, and for other purposes; Sponsor: Hudson, Richard [Rep.-R-NC-9]; Committees: House – Energy and Commerce; Ways and Means
H.R.1839 – To prohibit certain uses of xylazine, and for other purposes; Sponsor: Panetta, Jimmy [Rep.-D-CA-19]; Committees: House – Energy and Commerce; Judiciary
H.R.1843 – To amend the Internal Revenue Code of 1986 to permanently extend the exemption for telehealth services from certain high deductible health plan rules; Sponsor: Steel, Michelle [Rep.-R-CA-45]; Committees: House – Ways and Means
S.1024 – A bill to authorize the Secretary of Health and Human Services to award grants to eligible entities to develop and implement a comprehensive program to promote student access to defibrillation in public elementary schools and secondary schools; Sponsor: Booker, Cory A. [Sen.-D-NJ]; Committees: Senate – Health, Education, Labor, and Pensions
S.1026 – A bill to authorize the appropriation of funds to the Centers for Disease Control and Prevention for conducting or supporting research on firearms safety or gun violence prevention; Sponsor: Markey, Edward J. [Sen.-D-MA]; Committees: Senate – Health, Education, Labor, and Pensions
S.1028 – A bill to amend title 38, United States Code, to expand health care and benefits from the Department of Veterans Affairs for military sexual trauma, and for other purposes; Sponsor: Tester, Jon [Sen.-D-MT]; Committees: Senate – Veterans’ Affairs
S.1031 – A bill to ensure affordable abortion coverage and care for every person, and for other purposes; Sponsor: Duckworth, Tammy [Sen.-D-IL]; Committees: Senate – Health, Education, Labor, and Pensions
S.1037 – A bill to prohibit the Secretary of Veterans Affairs from carrying out certain activities under the Electronic Health Record Modernization Program until certification of system stability improvements; Sponsor: Moran, Jerry [Sen.- R-KS]; Committees: Senate – Veterans’ Affairs
S.1038 – A bill to amend title XIX of the Social Security Act to improve transparency and prevent the use of abusive spread pricing and related practices in the Medicaid program; Sponsor: Welch, Peter [Sen.-D-VT]; Committees: Senate – Finance
S.1040 – A bill to amend title 38, United States Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, and for other purposes; Sponsor: Durbin, Richard J. [Sen.-D-IL]; Committees: Senate – Veterans’ Affairs
S.1057 – A bill to require responsiveness testing of Defense Logistics Agency pharmaceutical contracts; Sponsor: Rubio, Marco [Sen.-R-FL]; Committees: Senate – Armed Services
S.1063 – A bill to amend title XIX of the Social Security Act to implement a minimum work requirement for able-bodied adults enrolled in State Medicaid programs; Sponsor: Kennedy, John [Sen.-R-LA]; Committees: Senate – Finance
S.1064 – A bill to direct the Secretary of Health and Human Services to carry out a national project to prevent and cure Parkinson’s, to be known as the National Parkinson’s Project, and for other purposes; Sponsor: Capito, Shelley Moore [Sen.- R-WV]; Committees: Senate – Health, Education, Labor, and Pensions
S.1067 – A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions; Sponsor: Shaheen, Jeanne [Sen.-D-NH]; Committees: Senate – Health, Education, Labor, and Pensions
H.R.2392 – To require a seven-day waiting period before the receipt of a firearm; Sponsor: Slotkin, Elissa [Rep.-D-MI-7]; Committees: House – Judiciary
H.R.2391 – To amend title 18, United States Code, to temporarily prohibit the transfer of a firearm to, or the possession of a firearm by, a person convicted of a misdemeanor in which a firearm was used, carried, or possessed; Sponsor: Slotkin, Elissa [Rep.-D-MI-7]; Committees: House – Judiciary
H.R.2390 – To authorize the appropriation of funds to the Centers for Disease Control and Prevention for conducting or supporting research on firearms safety or gun violence prevention; Sponsor: Slotkin, Elissa [Rep.-D-MI-7]; Committees: House – Energy and Commerce
H.R.2389 – To amend title XVIII of the Social Security Act to provide for the distribution of additional residency positions, and for other purposes; Sponsor: Sewell, Terri A. [Rep.-D-AL-7]; Committees: House – Ways and Means; Energy and Commerce
H.R.2377 – To amend title XVIII of the Social Security Act to improve the accuracy of market-based Medicare payment for clinical diagnostic laboratory services, to reduce administrative burdens in the collection of data, and for other purposes; Sponsor: Hudson, Richard [Rep.-R-NC-9]; Committees: House – Energy and Commerce; Ways and Means
H.R.2376 – To amend the Indian Health Care Improvement Act and title 5 of the United States Code to facilitate participation in Federal benefits programs, and for other purposes; Sponsor: Grijalva, Raúl M. [Rep.-D-AZ-7]; Committees: House – Oversight and Accountability; Natural Resources; Energy and Commerce
H.R.2370 – To authorize the Secretary of Health and Human Services to award grants to eligible entities to develop and implement a comprehensive program to promote student access to defibrillation in public elementary schools and secondary schools; Sponsor: Cherfilus-McCormick, Sheila [Rep.-D-FL-20]; Committees: House – Energy and Commerce; Education and the Workforce
H.R.2369 – To amend the Federal Food, Drug, and Cosmetic Act with respect to in vitro clinical tests, and for other purposes; Sponsor: Bucshon, Larry [Rep.-R-IN-8]; Committees: House – Energy and Commerce; Ways and Means
H.R.2365 – To direct the Secretary of Health and Human Services to carry out a national project to prevent and cure Parkinson’s, to be known as the National Parkinson’s Project, and for other purposes; Sponsor: Bilirakis, Gus M. [Rep.-R- FL-12]; Committees: House – Energy and Commerce
H.R.2335 – To provide for a limitation on availability of funds for Bilateral Economic Assistance, Global Health Programs, HIV/AIDS for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Foreign Affairs
H.R.2334 – To provide for a limitation on availability of funds for Bilateral Economic Assistance, Global Health Programs for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Foreign Affairs
H.R.2297 – To provide for a limitation on availability of funds for Related Agency and Food and Drug Administration, FDA Innovation Account, Cures Act for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.2296 – To provide for a limitation on availability of funds for Related Agency and Food and Drug Administration, Buildings and Facilities for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.2295 – To provide for a limitation on availability of funds for Related Agency and Food and Drug Administration, Department of Health and Human Services, Food and Drug Administration, for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.2104 – To provide for a limitation on availability of funds for District of Columbia, Federal Payment for Testing and Treatment of HIV/AIDS for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Oversight and Accountability
H.R.2021 – To provide for a limitation on availability of funds for Department of Health and Human Services, Public Health and Social Services Emergency Fund for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.2020 – To provide for a limitation on availability of funds for Department of Health and Human Services, Office for Civil Rights for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5] Committees: House – Energy and Commerce
H.R.2019 – To provide for a limitation on availability of funds for Department of Health and Human Services, Office of the Inspector General for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce; Natural Resources; Education and the Workforce; Ways and Means
H.R.2018 – To provide for a limitation on availability of funds for Department of Health and Human Services, Office of the Secretary, Office of the National Coordinator for Health Information Technology for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.2017 – To provide for a limitation on availability of funds for Department of Health and Human Services, Office of the Secretary, Office of Medicare Hearings and Appeals for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Ways and Means; Energy and Commerce
H.R.2016 – To provide for a limitation on availability of funds for Department of Health and Human Services, Office of the Secretary, General Departmental Maintenance for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce; Natural Resources; Education and the Workforce; Ways and Means
H.R.2015 – To provide for a limitation on availability of funds for Department of Health and Human Services, Administration for Community Living, Aging and Disability Services Programs for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Education and the Workforce; Energy and Commerce; Ways and Means; House Administration
H.R.2006 – To provide for a limitation on availability of funds for Department of Health and Human Services, The Agency for Heathcare Research and Quality for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.2005 – To provide for a limitation on availability of funds for Department of Health and Human Services, Substance Abuse and Mental Health Services Administration Health Surveillance and Program Support for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.2004 – To provide for a limitation on availability of funds for Department of Health and Human Services, Substance Abuse and Mental Health Services Administration Substance Abuse Prevention for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.2003 – To provide for a limitation on availability of funds for Department of Health and Human Services, Substance Abuse and Mental Health Services Administration Substance Abuse Treatment for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.2002 – To provide for a limitation on availability of funds for Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Mental Health for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R- AZ-5]; Committees: House – Energy and Commerce
H.R.2001 – To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health Innovation Account, CURES Act for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.2000 – To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health Buildings and Facilities for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.1999 – To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health Office of the Director for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.1998 – To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Center for Advancing Translational Sciences for fiscal year 2024; Sponsor: Biggs, Andy [Rep.- R-AZ-5]; Committees: House – Energy and Commerce
H.R.1997 – To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Library of Medicine for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.1996 – To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health John E. Fogarty International Center for fiscal year 2024. Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.1995 – To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institute on Minority Health and Health Disparities for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.1994 – To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Center for Complementary and Integrative Health for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.1993 – To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institute of Biomedical Imaging and Bioengineering for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.1992 – To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Human Genome Research for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.1991 – To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institute of Mental Health for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.1990 – To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institute on Drug Abuse for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.1988 – To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institute of Nursing Research for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.1986 – 118th Congress (2023-2024) To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.1985 – To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institute on Aging for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.1983 – To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Eye Institute for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.1980 – To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Disease for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R- AZ-5]; Committees: House – Energy and Commerce
H.R.1979 – To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institute of Neurological Disorders and Stroke for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.1978 – To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.1976 – To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Heart, Lung, and Blood Institute for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.1975 – To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Cancer Institute for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.1974 – To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease Control and Prevention-Wide Activities and Program Support for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R- AZ-5]; Committees: House – Energy and Commerce
H.R.1973 – To provide for a limitation on availability of Department of Health and Human Services, Centers for Disease Control and Prevention Buildings and Facilities for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.1972 – To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease Control and Prevention Public Health Preparedness and Response for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.1971 – To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease Control and Prevention Global Health for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.1968 – To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease Control and Prevention Injury Prevention and Control for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.1963 – To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease Control and Prevention Emerging and Zoonotic Infectious Diseases for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.1962 – To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease Control and Prevention HIV/AIDS, Viral Hepatitis, Sexually Transmitted Diseases, and Tuberculosis Prevention for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.1961 – To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease Control and Prevention Immunization and Respiratory Diseases for fiscal year 2024; Sponsor: Biggs, Andy [Rep.- R-AZ-5]; Committees: House – Energy and Commerce
H.R.1960 – To provide for a limitation on availability of funds for Department of Health and Human Services, Health Resources and Services Administration Program Management for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce
H.R.1958 – To provide for a limitation on availability of funds for Department of Health and Human Services, Health Resources and Services Administration Rural Health for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Energy and Commerce; Ways and Means
H.R.1956 – To provide for a limitation on availability of funds for Department of Health and Human Services, Health Resources and Services Administration Ryan White HIV/AIDS Program for fiscal year 2024; Sponsor: Biggs, Andy [Rep.- R-AZ-5]; House – Energy and Commerce
H.R.1955 – To provide for a limitation on availability of funds for Department of Health and Human Services, Health Resources and Services Administration Maternal and Child Health for fiscal year 2024; Sponsor: Biggs, Andy [Rep.-R- AZ-5]; Committees: House – Energy and Commerce
H.Res.264 – Expressing support for the goals of Workplace Eye Wellness Month by promoting the importance of protecting the eyes from increased screen time; Sponsor: Payne, Donald M., Jr. [Rep.-D-NJ-10]; Committees: House – Education and the Workforce; Energy and Commerce
S.Res.139 – A resolution recognizing the critical role that PEPFAR has played in the global fight against HIV/AIDS; Sponsor: Graham, Lindsey [Sen.-R-SC]; Committees: Senate – Foreign Relations
S.Res.144 – A resolution recognizing that it is the duty of the Federal Government to develop and implement a Transgender Bill of Rights to protect and codify the rights of transgender and nonbinary people under the law and ensure their access to medical care, shelter, safety, and economic safety; Sponsor: Markey, Edward J. [Sen.-D-MA]; Committees: Senate – Judiciary
S.Res.149 – A resolution designating the first week of April 2023 as “National Asbestos Awareness Week”; Sponsor: Tester, Jon [Sen.-D-MT]; Submitted in the Senate, considered, and agreed to without amendment by Unanimous Consent.
S.Res.153 – A resolution recognizing the roles and the contributions of care workers in the United States and expressing support for the designation of April 2023 as “Care Worker Recognition Month”; Sponsor: Casey, Robert P., Jr. [Sen.-D-PA]; Committees: Senate – Health, Education, Labor, and Pensions
S.1069 – A bill to amend the Toxic Substances Control Act to prohibit the manufacture, processing, use, and distribution in commerce of commercial asbestos and mixtures and articles containing commercial asbestos, and for other purposes; Sponsor: Merkley, Jeff [Sen.-D-OR]; Committees: Senate – Environment and Public Works
S.1072 – A bill to create a Council on Emergency Response Protocols to ensure the establishment of accessible, developmentally appropriate, culturally aware, and trauma-informed emergency response protocols in public schools, early child care and education settings, and institutions of higher education, and for other purposes; Sponsor: Casey, Robert P., Jr. [Sen.-D-PA]; Committees: Senate – Health, Education, Labor, and Pensions
S.1075 – A bill to direct the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to establish a grant program to be known as the Mental Health Licensure Portability Program to award grants to eligible entities, and for other purposes; Sponsor: King, Angus S., Jr. [Sen.-I-ME]; Committees: Senate – Health, Education, Labor, and Pensions
S.1077 – A bill to establish a home-based telemental health care demonstration program for purposes of increasing mental health and substance use services in rural medically underserved populations and for individuals in farming, fishing, and forestry occupations; Sponsor: Rounds, Mike [Sen.-R-SD]; Committees: Senate – Health, Education, Labor, and Pensions
S.1110 – A bill to amend title XVIII of the Social Security Act to rebase the calculation of payments for sole community hospitals and Medicare-dependent hospitals, and for other purposes; Sponsor: Casey, Robert P., Jr. [Sen.-D-PA]; Committees: Senate – Finance
S.1113 – A bill to amend the Public Health Service Act to establish direct care registered nurse-to-patient staffing ratio requirements in hospitals, and for other purposes; Sponsor: Brown, Sherrod [Sen.-D-OH]; Committees: Senate – Health, Education, Labor, and Pensions
S.1114 – A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period; Sponsor: Smith, Tina [Sen.-D-MN]; Committees: Senate – Health, Education, Labor, and Pensions
S.1115 – A bill to require the Secretary of Labor to revise the Standard Occupational Classification System to accurately count the number of emergency medical services practitioners in the United States; Sponsor: Casey, Robert P., Jr. [Sen.-D- PA]; Committees: Senate – Health, Education, Labor, and Pensions
S.1119 – A bill to amend title 38, United States Code, to increase the maximum age for children eligible for medical care under the CHAMPVA program, and for other purposes; Sponsor: Brown, Sherrod [Sen.-D-OH]; Committees: Senate – Veterans’ Affairs
S.1120 – A bill to improve the actions available to eligible product developers in the event of delays in receiving covered product for purposes of generic drug or biosimilar biological product development; Sponsor: Hassan, Margaret Wood [Sen.-D-NH]; Committees: Senate – Health, Education, Labor, and Pensions
S.1122 – A bill to improve the program to provide for priority review of human drug applications to encourage treatment for agents that present national security threats; Sponsor: Ernst, Joni [Sen.-R-IA]; Committees: Senate – Health, Education, Labor, and Pensions
S.1125 – A bill to authorize an electronic health record modernization program of the Department of Veterans Affairs and increase oversight and accountability of the program to better serve veterans, medical professionals of the Department, and taxpayers, and for other purposes; Sponsor: Tester, Jon [Sen.-D-MT]; Committees: Senate – Veterans’ Affairs
S.1128 – A bill to establish special rules relating to information provided with respect to drug applications concerning method of use patents; Sponsor: Hassan, Margaret Wood [Sen.-D-NH]; Committees: Senate – Health, Education, Labor, and Pensions
S.1130 – A bill to amend the Public Health Service Act to provide for hospital and insurer price transparency; Sponsor: Braun, Mike [Sen.-R-IN]; Committees: Senate – Health, Education, Labor, and Pensions
S.1131 – A bill to amend title XI of the Social Security Act and title XXVII of the Public Health Service Act to establish requirements with respect to prescription drug benefits; Sponsor: Braun, Mike [Sen.-R-IN]; Committees: Senate – Health, Education, Labor, and Pensions
S.1132 – A bill to allow sponsors of certain new drug applications to rely upon investigations conducted in certain foreign countries, and for other purposes; Sponsor: Braun, Mike [Sen.-R-IN]; Committees: Senate – Health, Education, Labor, and Pensions
S.1133 – A bill to amend the Public Health Service Act to clarify rules relating to drug discounts for covered entities; Sponsor: Braun, Mike [Sen.-R-IN]; Committees: Senate – Health, Education, Labor, and Pensions
S.1134 – A bill to strengthen the authority of the Food and Drug Administration with respect to foreign drug facility inspections; Sponsor: Braun, Mike [Sen.-R-IN]; Committees: Senate – Health, Education, Labor, and Pensions
S.1135 – A bill to amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, the Internal Revenue Code of 1986, and the Patient Protection and Affordable Care Act to require coverage of hearing devices and systems in certain private health insurance plans, and for other purposes; Sponsor: Capito, Shelley Moore [Sen.-R-WV]; Committees: Senate – Health, Education, Labor, and Pensions
S.1139 – A bill to amend title XVIII of the Social Security Act to apply prescription drug inflation rebates to drugs furnished in the commercial market and to change the base year for rebate calculations; Sponsor: Cortez Masto, Catherine [Sen.-D-NV]; Committees: Senate – Finance
S.1140 – A bill to amend the Public Health Service Act with respect to the designation of general surgery shortage areas, and for other purposes; Sponsor: Schatz, Brian [Sen.-D-HI]; Committees: Senate – Health, Education, Labor, and Pensions
S.1141 – A bill to amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes; Sponsor: Cassidy, Bill [Sen.-R-LA]; Committees: Senate – Judiciary
S.1143 – A bill to direct the Secretary of Defense to carry out a grant program to increase cooperation on post-traumatic stress disorder research between the United States and Israel; Sponsor: Moran, Jerry [Sen.-R-KS]; Committees: Senate – Foreign Relations
S.1150 – A bill to amend the Public Health Service Act to support and stabilize the existing nursing workforce, establish programs to increase the number of nurses, and for other purposes; Sponsor: Merkley, Jeff [Sen.-D-OR]; Committees: Senate – Health, Education, Labor, and Pensions
S.1158 – A bill to amend the Internal Revenue Code of 1986 to improve access to health care through expanded health savings accounts, and for other purposes; Sponsor: Rubio, Marco [Sen.-R-FL]; Committees: Senate – Finance
H.Res.269 – Recognizing that it is the duty of the Federal Government to develop and implement a Transgender Bill of Rights to protect and codify the rights of transgender and nonbinary people under the law and ensure their access to medical care, shelter, safety, and economic security; Sponsor: Jayapal, Pramila [Rep.-D-WA-7]; Committees: House – Judiciary; Education and the Workforce; Energy and Commerce; Financial Services; Oversight and Accountability
H.R.12 – To protect a person’s ability to determine whether to continue or end a pregnancy, and to protect a health care provider’s ability to provide abortion services; Sponsor: Chu, Judy [Rep.-D-CA-28]; Committees: House – Energy and Commerce; Judiciary
H.R.2400 – To amend title XIX of the Social Security Act to allow States to make medical assistance available to inmates during the 30-day period preceding their release; Sponsor: Tonko, Paul [Rep.-D-NY-20]; Committees: House – Energy and Commerce
H.R.2402 – To amend the Toxic Substances Control Act to prohibit the manufacture, processing, use, and distribution in commerce of commercial asbestos and mixtures and articles containing commercial asbestos, and for other purposes; Sponsor: Bonamici, Suzanne [Rep.-D-OR-1]; Committees: House – Energy and Commerce
H.R.2407 – To amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests; Sponsor: Arrington, Jodey C. [Rep.-R-TX-19]; Committees: House – Energy and Commerce; Ways and Means
H.R.2408 – To amend title XVIII of the Social Security Act to provide a review process for adverse national coverage determinations with respect to drug coverage under the Medicare program; Sponsor: Barragan, Nanette Diaz [Rep.-D- CA-44]; Committees: House – Ways and Means; Energy and Commerce
H.R.2410 – To amend title 38, United States Code, to authorize the Secretary of Veterans Affairs to provide administrative support to providers of dental care who provide such care to veterans that is not furnished under such title, to direct the Secretary of Veterans Affairs to establish a pilot program for the provision of dental care to certain veterans, and for other purposes; Sponsor: Bilirakis, Gus M. [Rep.-R-FL-12]; Committees: House – Veterans’ Affairs
H.R.2411 – To amend the Public Health Service Act to support and stabilize the existing nursing workforce, establish programs to increase the number of nurses, and for other purposes; Sponsor: Blunt Rochester, Lisa [Rep.-D-DE-At Large]; Committees: House – Energy and Commerce
H.R.2412 – To amend the Public Health Service Act to authorize grants to increase national capacity to provide pediatric behavioral health services at children’s hospitals and through community-based providers to improve children’s access to care; and to authorize grants to begin to address large numbers of children boarding in emergency departments, to support the pediatric behavioral health workforce, and for other purposes; Sponsor: Blunt Rochester, Lisa [Rep.-D-DE-At Large]; Committees: House – Energy and Commerce
H.R.2413 – To amend title 38, United States Code, to require the Secretary of Veterans Affairs to furnish dental care in the same manner as any other medical service, and for other purposes; Sponsor: Brownley, Julia [Rep.-D-CA-26]; Committees: House – Veterans’ Affairs
H.R.2414 – To amend title 38, United States Code, to increase the maximum age for children eligible for medical care under the CHAMPVA program, and for other purposes; Sponsor: Brownley, Julia [Rep.-D-CA-26]; Committees: House – Veterans’ Affairs
H.R.2416 – To amend the Public Health Service Act to reauthorize a military and civilian partnership for trauma readiness grant program; Sponsor: Burgess, Michael C. [Rep.-R-TX-26]; Committees: House – Energy and Commerce
H.R.2430 – To create a rule of construction for Federal courts to apply in all cases regarding the provision or obtaining of reproductive health services and the imposition of capital punishment; Sponsor: Mace, Nancy [Rep.-R-SC-1]; Committees: House – Judiciary
H.R.2431 – To authorize Department of Veterans Affairs health care providers to provide recommendations and opinions to veterans regarding participation in State marijuana programs; Sponsor: Mast, Brian J. [Rep.-R-FL-21]; Committees: House – Veterans’ Affairs
H.R.2433 – To amend title XVIII of the Social Security Act to update the calculation of the hospital specific rate for such hospitals, and for other purposes; Sponsor: Meuser, Daniel [Rep.-R-PA-9]; Committees: House – Ways and Means
H.R.2438 – To direct the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to establish a grant program to be known as the Mental Health Licensure Portability Program to award grants to eligible entities, and for other purposes; Sponsor: Neguse, Joe [Rep.-D-CO-2]; Committees: House – Energy and Commerce
H.R.2439 – To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, the Internal Revenue Code of 1986, and the Patient Protection and Affordable Care Act to require coverage of hearing devices and systems in certain private health insurance plans, and for other purposes; Sponsor: Neguse, Joe [Rep.- D-CO-2]; Committees: House – Energy and Commerce; Education and the Workforce; Ways and Means
H.R.2441 – To amend title 38, United States Code, to expand health care and benefits from the Department of Veterans Affairs for military sexual trauma, and for other purposes; Sponsor: Pingree, Chellie [Rep.-D-ME-1]; Committees: House – Veterans’ Affairs; Armed Services
H.R.2454 – To direct the Secretary of Defense to carry out a grant program to increase cooperation on post-traumatic stress disorder research between the United States and Israel; Sponsor: Waltz, Michael [Rep.-R-FL-6]; Committees: House – Armed Services
H.R.2456 – To direct the Secretary of Health and Human Services, acting through the Deputy Assistant Secretary for Women’s Health, to create educational materials with respect to covered disorders for elementary and secondary school students, and for other purposes; Sponsor: Williams, Nikema [Rep.-D-GA-5]; Committees: House – Education and the Workforce; Energy and Commerce